急性肾损伤中随机尿蛋白肌酐比与白蛋白肌酐比的可靠性:队列研究
结果显示活动期一致性较差且限界宽,恢复期改善,但两期随机尿比值均系统性高估24小时排泄36%至56%。
要点
- AKI活动期随机尿UACR与UPCR同24小时尿一致性低于恢复期。
- 两期随机尿比值均系统性高估24小时尿蛋白或白蛋白排泄36%至56%。
- 基线肾功能保留、严重AKI及血流动力学病因者随机尿值不可靠更明显。
核心结论
- AKI活动期随机尿UPCR和UACR与24小时尿采集的一致性显著低于恢复期,临床用于评估基线蛋白尿或监测治疗反应时需谨慎。
主要发现
- AKI活动期CCC为UACR 0.81、UPCR 0.68,恢复期升至UACR 0.89、UPCR 0.83(p=0.001)。
- AKI活动期限界为UACR 0.22至8.37、UPCR 0.31至7.99,恢复期缩窄至UACR 0.40至5.48、UPCR 0.47至4.91。
- 随机尿比值在AKI活动期和恢复期均系统性高估24小时采集36%至56%。
- 随机尿值不可靠在基线肾功能保留、严重AKI和血流动力学病因患者中最明显。
临床怎么用
- AKI活动期不宜仅凭随机尿UPCR或UACR确定基线蛋白尿或判断治疗反应。
- 对基线肾功能保留、严重AKI或血流动力学病因患者,解读随机尿比值需格外谨慎。
局限性
- 以血清肌酐定义AKI恢复可能未反映AKI完全缓解。
- 仅纳入住院患者,可能限制对门诊较轻AKI的推广性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Spot urine protein-to-creatinine (UPCR) and albumin-to-creatinine (UACR) ratios are common surrogates for 24-hour excretion, but their validity during acute kidney injury (AKI) is uncertain because kidney function is not at steady state. This study assessed the validity of these spot ratios during active AKI compared to after its resolution. STUDY DESIGN: A prospective paired cohort study. SETTING & PARTICIPANTS: One hundred hospitalized adult patients with AKI at a single center in Thailand. EXPOSURE: Active phase of AKI was the period between diagnosis and resolution, which was defined as the return of serum creatinine to baseline or a value ≥50% below the peak value, sustained for ≥48 hours. OUTCOMES: The agreement and reliability between protein-to-creatine and albumin-to-creatinine ratios in spot urine samples versus in 24-hour urine collections. ANALYTICAL APPROACH: Agreement was evaluated using Lin's Concordance Correlation Coefficient (CCC) and Bland-Altman analysis to quantify systematic bias and random error. Limits of Agreement (LoA) were defined as the range within which 95% of the differences between the two measurement methods were expected to fall. RESULTS: Spot ratios differed from 24-hour collections during AKI (CCC: UACR 0.81; UPCR 0.68) and became more reliable after recovery, (CCC: UACR 0.89; UPCR 0.83) (p=0.001). Limits of agreement were wide during AKI (UACR 0.22 to 8.37; UPCR 0.31 to 7.99) and narrowed significantly upon resolution (UACR 0.40 to 5.48; UPCR 0.47 to 4.91). Spot ratios systematically overestimated the 24-hour collections by 36% to 56% both during and after resolution of AKI. The unreliability of the spot urine values was most pronounced in patients with preserved baseline kidney function, severe AKI, and hemodynamic etiologies. LIMITATIONS: Defining resolution via serum creatinine may not reflect complete resolution of AKI. The exclusively hospitalized cohort may limit generalizability to milder AKI occurring in the outpatient setting. CONCLUSIONS: Spot urine ratios exhibit significant imprecision during active AKI compared to following its resolution. Clinicians should exercise caution when using these data to establish baseline proteinuria or monitor treatment response during AKI.
引用
- Suwatronnakorn B, Wipattanakitcharoen A, Wuttiputhanun T, et al. Reliability of Spot Urine Protein-to-Creatinine and Urine Albumin-to-Creatinine Ratios in Acute Kidney Injury: A Cohort Study. Am J Kidney Dis. 2026. PMID: 42901297. doi:10.1053/j.ajkd.2026.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。